Text size Photograph by JOSEPH PREZIOSO / AFP via Getty Images The Modern biotechnology company, which has received commitments of nearly $ 1 billion from the federal government to develop its Covid-19 vaccine, seeks to sell the vaccine for between $ 25 and $ 30 per dose, the Financial Times …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna. . That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »
The UK government said on Monday it has secured early access to 90 million doses of vaccines from two potential COVID-19 vaccines developed by a partnership between Germany’s BioNTech and US drug maker Pfizer, as well as one by the group. French Valneva. The business ministry said it had signed …
Read More »